Illumina, Inc. - stock earnings
ILMN Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 2, 2024 AfterMarket | 0.09 / 0.04 | - | 1.1 billion / 1.1 billion | - |
ILMN Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -176.0 million USD | 1.1 billion USD |
2023Q3 | -754.0 million USD | 1.1 billion USD |
2023Q2 | -234.0 million USD | 1.2 billion USD |
2023Q1 | 3.0 million USD | 1.1 billion USD |
2022Q4 | -140.0 million USD | 1.1 billion USD |
2022Q3 | -3.8 billion USD | 1.1 billion USD |
2022Q2 | -535.0 million USD | 1.2 billion USD |
2022Q1 | 86.0 million USD | 1.2 billion USD |
2021Q4 | 112.0 million USD | 1.2 billion USD |
2021Q3 | 317.0 million USD | 1.1 billion USD |
2021Q2 | 185.0 million USD | 1.1 billion USD |
2021Q1 | 147.0 million USD | 1.1 billion USD |
2020Q4 | 257.0 million USD | 953.0 million USD |
2020Q3 | 179.0 million USD | 794.0 million USD |
2020Q2 | 47.0 million USD | 633.0 million USD |
2020Q1 | 173.0 million USD | 859.0 million USD |
2019Q4 | 239.0 million USD | 953.0 million USD |
2019Q3 | 234.0 million USD | 907.0 million USD |
2019Q2 | 296.0 million USD | 838.0 million USD |
2019Q1 | 233.0 million USD | 846.0 million USD |
2018Q4 | 210.0 million USD | 867.0 million USD |
2018Q3 | 199.0 million USD | 853.0 million USD |
2018Q2 | 209.0 million USD | 830.0 million USD |
2018Q1 | 208.0 million USD | 782.0 million USD |
2017Q4 | 68.0 million USD | 778.0 million USD |
2017Q3 | 163.0 million USD | 714.0 million USD |
2017Q2 | 128.0 million USD | 662.0 million USD |
2017Q1 | 373.0 million USD | 598.0 million USD |
2016Q4 | 123.8 million USD | 619.3 million USD |
2016Q3 | 128.9 million USD | 607.1 million USD |
2016Q2 | 120.4 million USD | 600.1 million USD |
2016Q1 | 89.6 million USD | 571.8 million USD |
2015Q4 | 104.5 million USD | 591.5 million USD |
2015Q3 | 118.2 million USD | 550.3 million USD |
2015Q2 | 102.2 million USD | 539.4 million USD |
2015Q1 | 136.7 million USD | 538.6 million USD |
2014Q4 | 153.3 million USD | 512.4 million USD |
2014Q3 | 93.5 million USD | 480.6 million USD |
2014Q2 | 46.6 million USD | 447.6 million USD |
2014Q1 | 60.0 million USD | 420.8 million USD |
2013Q4 | 80.7 million USD | 387.3 million USD |
2013Q3 | 31.4 million USD | 356.8 million USD |
2013Q2 | 35.9 million USD | 346.1 million USD |
2013Q1 | -22.6 million USD | 331.0 million USD |
2012Q4 | 71.9 million USD | 309.3 million USD |
2012Q3 | 29.7 million USD | 285.9 million USD |
2012Q2 | 23.4 million USD | 280.6 million USD |
2012Q1 | 26.2 million USD | 272.8 million USD |
2011Q4 | 11.7 million USD | 250.1 million USD |
2011Q3 | 20.2 million USD | 235.5 million USD |
2011Q2 | 30.6 million USD | 287.5 million USD |
2011Q1 | 24.1 million USD | 282.5 million USD |
2010Q4 | 38.4 million USD | 261.3 million USD |
2010Q3 | 35.4 million USD | 237.3 million USD |
2010Q2 | 29.8 million USD | 212.0 million USD |
2010Q1 | 21.2 million USD | 192.1 million USD |
2009Q4 | 11.7 million USD | 180.6 million USD |
2009Q3 | 17.1 million USD | 158.4 million USD |
2009Q2 | 24.7 million USD | 161.6 million USD |
2009Q1 | 18.8 million USD | 165.8 million USD |
2008Q4 | 28.9 million USD | 160.9 million USD |
2008Q3 | -7.3 million USD | 150.3 million USD |
2008Q2 | 15.4 million USD | 140.2 million USD |
2008Q1 | 13.4 million USD | 121.9 million USD |
2007Q4 | -4.0 million USD | 112.6 million USD |
2007Q3 | 14.5 million USD | 97.5 million USD |
2007Q2 | 9.3 million USD | 84.5 million USD |
2007Q1 | -298.1 million USD | 72.2 million USD |
2006Q4 | 17.1 million USD | 60.4 million USD |
2006Q3 | 16.2 million USD | 53.5 million USD |
2006Q2 | 6.8 million USD | 41.6 million USD |
2006Q1 | -104000 USD | 29.1 million USD |
2005Q4 | 326000 USD | 23.0 million USD |
2005Q3 | -1.4 million USD | 19.5 million USD |
2005Q2 | -18.5 million USD | 15.8 million USD |
2005Q1 | -1.2 million USD | 15.1 million USD |
2004Q4 | 6.5 million USD | 14.8 million USD |
2004Q3 | -2.0 million USD | 13.5 million USD |
2004Q2 | -3.5 million USD | 11.5 million USD |
2004Q1 | -4.3 million USD | 10.8 million USD |
2003Q4 | -4.4 million USD | 10.7 million USD |
2003Q3 | -5.5 million USD | 8.2 million USD |
2003Q2 | -9.0 million USD | 4.8 million USD |
2003Q1 | -9.3 million USD | 4.3 million USD |
2002Q4 | -8.0 million USD | 3.9 million USD |
2002Q3 | -7.6 million USD | 3.0 million USD |
2002Q2 | -31.8 million USD | 1.9 million USD |
2002Q1 | -8.7 million USD | 1.3 million USD |
2001Q4 | -8.2 million USD | 761112 USD |
2001Q3 | -5.8 million USD | 691356 USD |
2001Q2 | -5.9 million USD | 469840 USD |
2001Q1 | -4.9 million USD | 563692 USD |
2000Q4 | -4.6 million USD | 484665 USD |
2000Q3 | -3.9 million USD | 662589 USD |
2000Q2 | -5.3 million USD | 78652 USD |
2000Q1 | -4.8 million USD | 83205 USD |
ILMN Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -1.2 billion USD | 4.5 billion USD |
2022 | -4.4 billion USD | 4.6 billion USD |
2021 | 762.0 million USD | 4.5 billion USD |
2020 | 656.0 million USD | 3.2 billion USD |
2019 | 1.0 billion USD | 3.5 billion USD |
2018 | 826.0 million USD | 3.3 billion USD |
2017 | 726.0 million USD | 2.8 billion USD |
2016 | 462.6 million USD | 2.4 billion USD |
2015 | 461.6 million USD | 2.2 billion USD |
2014 | 353.4 million USD | 1.9 billion USD |
2013 | 125.3 million USD | 1.4 billion USD |
2012 | 151.3 million USD | 1.1 billion USD |
2011 | 86.6 million USD | 1.1 billion USD |
2010 | 124.9 million USD | 902.7 million USD |
2009 | 72.3 million USD | 666.3 million USD |
2008 | 50.5 million USD | 573.2 million USD |
2007 | -278.4 million USD | 366.8 million USD |
2006 | 40.0 million USD | 184.6 million USD |
2005 | -20.9 million USD | 73.5 million USD |
2004 | -6.2 million USD | 50.6 million USD |
2003 | -27.1 million USD | 28.0 million USD |
2002 | -40.3 million USD | 10.0 million USD |
2001 | -24.8 million USD | 2.5 million USD |
2000 | -18.6 million USD | 1.3 million USD |
1999 | -5.5 million USD | 474026 USD |
ILMN
Price: $117.93
52 week price:
Payout Ratio Range:
Earnings Per Share: -7.35 USD
P/E Ratio: -20.31
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.1 million
Ebitda: 273.0 millionMarket Capitalization: 19.8 billion